Phyllissa Schmiedlin‐Ren
- Oncology top 2%
- Pharmacology top 0.1%
- Pediatrics, Perinatology and Child Health top 1%
- Molecular Biology
- Genetics top 10%
- Co-authors
- Paul B. WatkinsKenneth S. LownJoseph C. KolarsKenneth E. ThummelJohn D. SchuetzMary F. PaineJeannine M. FisherWen-Sheng Guo
- Topics
- Pharmacogenetics and Drug Metabolism (11 papers)Inflammatory Bowel Disease (11 papers)Drug Transport and Resistance Mechanisms (6 papers)
- Cited by
- PharmacologyTransplantationOncology
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Phyllissa Schmiedlin‐Ren
30 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Oncology 1.3k
- Pharmacology 1.3k
- Pediatrics, Perinatology and Child Health 739
- Molecular Biology 354
- Genetics 302
Countries citing papers authored by Phyllissa Schmiedlin‐Ren
This map shows the geographic impact of Phyllissa Schmiedlin‐Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phyllissa Schmiedlin‐Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phyllissa Schmiedlin‐Ren more than expected).
Fields of papers citing papers by Phyllissa Schmiedlin‐Ren
This network shows the impact of papers produced by Phyllissa Schmiedlin‐Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phyllissa Schmiedlin‐Ren. The network helps show where Phyllissa Schmiedlin‐Ren may publish in the future.
Co-authorship network of co-authors of Phyllissa Schmiedlin‐Ren
This figure shows the co-authorship network connecting the top 25 collaborators of Phyllissa Schmiedlin‐Ren. A scholar is included among the top collaborators of Phyllissa Schmiedlin‐Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phyllissa Schmiedlin‐Ren. Phyllissa Schmiedlin‐Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 38 | |
| 3 | 75 | |
| 4 | 123 | |
| 5 | 31 | |
| 6 | 1 | |
| 7 | 17 | |
| 8 | 10 | |
| 9 | 7 | |
| 10 | The furocoumarin 6',7'-dihydroxybergamottin (DHB) accelerates CYp3A4 degradation via the ubiquitin-proteasomal pathway. | 6 |
| 11 | 34 | |
| 12 | 70 | |
| 13 | Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine*breakdown → | 576 |
| 14 | 276 | |
| 15 | 38 | |
| 16 | 321 | |
| 17 | 32 | |
| 18 | 22 | |
| 19 | 447 | |
| 20 | 60 |
About Phyllissa Schmiedlin‐Ren
Phyllissa Schmiedlin‐Ren is a scholar working on Pharmacology, Genetics and Transplantation, having authored 31 papers that have together received 2.5k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (11 papers), Inflammatory Bowel Disease (11 papers) and Drug Transport and Resistance Mechanisms (6 papers). The work is most often cited by research in Pharmacology (1.3k citations), Transplantation (216 citations) and Oncology (1.3k citations). Phyllissa Schmiedlin‐Ren has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Paul B. Watkins, Kenneth S. Lown, Joseph C. Kolars, Kenneth E. Thummel, John D. Schuetz, Mary F. Paine, Jeannine M. Fisher, Paul B. Watkins, Wen-Sheng Guo and Steven Wrighton. Their work appears in journals such as Journal of Clinical Investigation, Gastroenterology and Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.